The Asia Pacific Liver Health Supplements Market would witness market growth of 5.04% CAGR during the forecast period (2019-2025).
Asia-Pacific attained a dominant market share and the region has also been estimated to remain dominant over the forecast period. Some of the key factors contributing to this growth include growing incomes, increased prevalence of digestive tract diseases, and increasing awareness of organic process products are some of the factors that contribute to regional growth.
In addition, the rising standard of personalized nutrition among shoppers is expected to lead to regional growth for liver health supplements. The growth rate can be associated with the increased prevalence of various diseases of the digestive tract, rising incomes and increased awareness of high nutritional ingredients in health products. In addition, the growing standard of personalized nutrition among people in the region is another significant factor.
The liver absorbs and breaks down all of the toxins found in the body to flush them out of the body. The health of the liver and its functionality is important for functioning the body healthily. Chronic liver disorders such as liver cirrhosis, liver hepatitis, non-alcoholic fatty liver diseases, etc. are prevalent because of reduced food quality, increased fast food and alcohol intake worldwide. Among all health supplements, the rate of growth in the consumption of liver health supplements has been demonstrating an increasing trend in recent years. Liver health supplements are available in the form of tablet, powder, liquid and soft gels.
Based on Form, the market is segmented into Capsules, Liquids, Tablets, Powders and Other Forms. Based on Product, the market is segmented into Herbal Supplements, Vitamins & Minerals and Other Products. The report also covers geographical segmentation of Liver Health Supplements market. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), The Himalaya Drug Company (Himalaya Global Holdings Ltd.), NOW Foods, Inc., Integria Healthcare (Australia) Pty Ltd., Enzymedica, Inc., Jarrow Formulas, Inc., Irwin Naturals, Inc., Gaia Herbs, Inc., Swanson Health Products, Inc. (Swander Pace Capital), and Nature’s Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG).
Scope of the Study
- Powders and
- Other Forms
- Herbal Supplements
- Vitamins & Minerals and
- Other Products
- South Korea
- Rest of Asia Pacific
- The Nature’s Bounty Co. (The Carlyle Group L.P.)
- The Himalaya Drug Company (Himalaya Global Holdings Ltd.)
- NOW Foods, Inc.
- Integria Healthcare (Australia) Pty Ltd.
- Enzymedica, Inc.
- Jarrow Formulas, Inc.
- Irwin Naturals, Inc.
- Gaia Herbs, Inc.
- Swanson Health Products, Inc. (Swander Pace Capital)
- Nature’s Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free